Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,175,305
  • Shares Outstanding, K 43,190
  • Annual Sales, $ 892,210 K
  • Annual Income, $ 32,190 K
  • 60-Month Beta 1.06
  • Price/Sales 6.73
  • Price/Cash Flow 38.22
  • Price/Book 6.00
Trade OMCL with:

Options Overview

Details
  • Implied Volatility 22.93%
  • Historical Volatility 18.33%
  • IV Percentile 0%
  • IV Rank 1.53%
  • IV High 59.94% on 12/08/20
  • IV Low 22.36% on 04/30/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 59
  • Put/Call OI Ratio 2.64
  • Today's Open Interest 5,728
  • Open Int (30-Day) 5,567

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.56
  • Number of Estimates 2
  • High Estimate 0.57
  • Low Estimate 0.56
  • Prior Year 0.16
  • Growth Rate Est. (year over year) +250.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
128.81 +11.28%
on 05/17/21
143.85 -0.35%
on 06/14/21
+11.43 (+8.66%)
since 05/14/21
3-Month
127.16 +12.72%
on 05/11/21
146.99 -2.48%
on 04/30/21
+3.13 (+2.23%)
since 03/15/21
52-Week
62.24 +130.30%
on 07/14/20
146.99 -2.48%
on 04/30/21
+77.25 (+116.89%)
since 06/15/20

Most Recent Stories

More News
CPSI vs. OMCL: Which Stock Is the Better Value Option?

CPSI vs. OMCL: Which Stock Is the Better Value Option?

CPSI : 33.75 (-0.35%)
OMCL : 143.84 (+0.60%)
Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?

Style Box ETF report for SPSM

SPSM : 44.27 (-0.44%)
OMCL : 143.84 (+0.60%)
GME : 212.86 (-7.23%)
SAIA : 210.87 (+0.63%)
IWM : 229.72 (-0.56%)
IJR : 113.68 (-0.25%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 190.52 (-0.28%)
OMCL : 143.84 (+0.60%)
NEO : 43.69 (+0.28%)
ENSG : 85.29 (+1.37%)
XLV : 124.49 (-0.14%)
VHT : 243.14 (-0.48%)
NXGN vs. OMCL: Which Stock Should Value Investors Buy Now?

NXGN vs. OMCL: Which Stock Is the Better Value Option?

NXGN : 17.27 (-2.21%)
OMCL : 143.84 (+0.60%)
LabCorp (LH) Base Line Growth Solid, COVID-Related Sales Drop

LabCorp's (LH) Walgreens-partnership expands to include new integrated digital experiences.

OMCL : 143.84 (+0.60%)
BSX : 42.49 (-0.12%)
LH : 260.91 (+0.42%)
WST : 343.83 (-0.38%)
Omnicell (OMCL) Q1 Earnings Beat Estimates, Margins Expand

Omnicell's (OMCL) raises adjusted EPS guidance for 2021 , which buoys optimism.

OMCL : 143.84 (+0.60%)
XRAY : 65.62 (+1.47%)
OMI : 46.25 (-1.13%)
SMLR : 109.0000 (+0.69%)
Omnicell (OMCL) Surpasses Q1 Earnings and Revenue Estimates

Omnicell (OMCL) delivered earnings and revenue surprises of 23.88% and 2.65%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

OMCL : 143.84 (+0.60%)
Scripps Health Selects Omnicell Medication Management Solutions to Help Improve Clinical and Operational Efficiency

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Scripps Health has selected the Company's...

OMCL : 143.84 (+0.60%)
Omnicell: Q1 Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported first-quarter earnings of $14.1 million.

OMCL : 143.84 (+0.60%)
Omnicell Announces Financial Results for First Quarter 2021

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its first quarter ended March...

OMCL : 143.84 (+0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Omnicell, Inc. is a leading provider of medication and supply management automation, analytics software, and medication adherence solutions for healthcare organizations. It works with healthcare providers to drive operational efficiency by removing tedious tasks and waste. Regardless of distribution...

See More

Key Turning Points

3rd Resistance Point 149.63
2nd Resistance Point 146.74
1st Resistance Point 144.86
Last Price 143.84
1st Support Level 140.09
2nd Support Level 137.20
3rd Support Level 135.32

See More

52-Week High 146.99
Last Price 143.84
Fibonacci 61.8% 114.62
Fibonacci 50% 104.62
Fibonacci 38.2% 94.61
52-Week Low 62.24

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar